2018•American Journal of Kidney DiseasesRequires access

Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)

Kimberly Smith, Aliza M. Thompson, David Baron, Steven T. Broadbent, Gary Lundstrom, Ronald D. Perrone

Open publisher page 20 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 20 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Autosomal dominant polycystic kidney disease, Polycystic kidney disease, Polycystic kidney, Kidney disease, Disease, Clinical trial, Kidney